Clinical trial
Targeted Therapy to Increase RAI Uptake in Patients With Metastatic Differentiated Thyroid Cancer
NCT05024929 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Therapy to Increase RAI Uptake in Patients With Metastatic Differentiated Thyroid Cancer
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 16, 2021
- Completion date
- February 1, 2033
- Enrollment
- 32 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
differentiated thyroid cancer, papillary thyroid cancer, pediatric cancer